Cabaletta Bio
Biotechnology, 2929 Arch St, Philadelphia, Pennsylvania, 19104, United States, 51-200 Employees
Phone Number: 26********
Who is CABALETTA BIO
Cabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies that have the potential to provide a deep an...
Read More
-
Headquarters: 2929 Arch St, Philadelphia, Pennsylvania, 19104, United States
-
Date Founded: 2017
-
Employees: 51-200
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2836
Does something look wrong? Fix it. | View contact records from CABALETTA BIO
Cabaletta Bio Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Cabaletta Bio
Answer: Cabaletta Bio's headquarters are located at 2929 Arch St, Philadelphia, Pennsylvania, 19104, United States
Answer: Cabaletta Bio's phone number is 26********
Answer: Cabaletta Bio's official website is https://cabalettabio.com
Answer: Cabaletta Bio's revenue is $25 Million to $50 Million
Answer: Cabaletta Bio's SIC: 2836
Answer: Cabaletta Bio has 51-200 employees
Answer: Cabaletta Bio is in Biotechnology
Answer: Cabaletta Bio contact info: Phone number: 26******** Website: https://cabalettabio.com
Answer: Cabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies that have the potential to provide a deep and durable, perhaps curative, treatment for patients with autoimmune diseases. The CABATM platform encompasses two strategies: the CARTA (chimeric antigen receptor T cells for autoimmunity) strategy, with CABA-201, a 4-1BB-containing fully human CD19-CAR T, as the lead product candidate being evaluated in systemic lupus erythematosus and myositis, and the CAART (chimeric autoantibody receptor T cells) strategy, with multiple clinical-stage candidates, including DSG3-CAART for mucosal pemphigus vulgaris and MuSK-CAART for MuSK myasthenia gravis. The expanding CABATM platform is designed to develop potentially curative therapies that offer deep and durable responses for patients with a broad range of autoimmune diseases. Cabaletta Bios headquarters and labs are located in Philadelphia, PA.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month